You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Patent: 7,744,886


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,744,886
Title:Methods for interfering with rank signaling
Abstract: Disclosed herein are methods for interfering with RANK signaling by administering blocking antibodies that bind a RANKL polypeptide and inhibit the binding of the RANKL polypeptide to a RANK polypeptide.
Inventor(s): Anderson; Dirk M (Port Townsend, WA)
Assignee: Immunex Corporation (Thousand Oaks, CA)
Application Number:12/214,914
Patent Claims:see list of patent claims

Details for Patent 7,744,886

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Amgen, Inc. PROLIA denosumab Injection 125320 06/01/2010 ⤷  Try a Trial 2016-12-23
Amgen, Inc. XGEVA denosumab Injection 125320 11/18/2010 ⤷  Try a Trial 2016-12-23
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 7,744,886

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 9958674 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 9828426 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 9828424 ⤷  Try a Trial
United States of America 8715683 ⤷  Try a Trial
United States of America 8569456 ⤷  Try a Trial
United States of America 8377690 ⤷  Try a Trial
United States of America 8333963 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.